Study of Autologous Total Immunoglobulin G Therapy for Atopic Dermatitis

Summary

This is a randomized, double-blind, placebo-controlled parallel group study on the efficacy and safety of intramuscular injections of autologous immunoglobulin in patients with moderate-to-severe atopic dermatitis.

Timeline

Start

2015-04-02

Primary completion

2017-03-27

Completion

2017-03-27

Drugs

Indications